 |
 |
 |
|
Sofosbuvir / Velpatasvir / Voxilaprevir in DAA Failure Patients with Cirrhosis.
Final Results of the French Compassionate Use Program
|
|
|
Reported by Jules Levin
AASLD 2018 San Francisco Nov 9-13
C Hezode1, D Guyader2, E Nguyen-Khac3, D Larrey4, V Di Martino5, A Minello-Franza6, N Giuily-Guigui7, S Mokhtari8, K Hartig-Lavie9, L Cotte9, D Ribard10, MA Valantin11, L Bonyhay11, M Antoni12, JP Bronowicki13, JM Combis14, C Pilette15, C Zamora8, D Poinsot9, JP Arpurt16, C Renou17, M Bourliere8, V Grando18, F Roudot-Thoraval1, LM Stamm19, V Canva20
Creteil1 - Rennes2 - Amiens3 - Montpellier4 - Besançon5 - Dijon6 - Clichy7 - Marseille8 - Lyon9 - Nimes10 - Paris11 - Orange12 - Nancy13 - Toulouse14 - Le Mans15 - Avignon16 - Hyères17 - Bondy18 - Lille20 , France & Gilead19



|
|
|
 |
 |
|
|